
We're #hiring a computational #postdoc! PhD in computer science or other quantitative field? Join our mission: push the boundaries of precision #oncology with computational #epigenomics and #AI. careers.dana-farber.org/job/… Please RT!
✓Genitourinary oncologist running a computational epigenomics lab @DanaFarber, Assistant Professor @harvardmed

We're #hiring a computational #postdoc! PhD in computer science or other quantitative field? Join our mission: push the boundaries of precision #oncology with computational #epigenomics and #AI. careers.dana-farber.org/job/… Please RT!

Takeaway: epigenomic liquid biopsy can query the effects of genetic variation on gene regulation across tissues and cell states. In followup work, we're finding this quite informative for dissecting GWAS risk loci. Thanks to @SashaGusevPosts and @LimingLiangHSPH for the collab!

Integrating cfcQTLs with genetic association studies linked 4,891 loci to 1,011 traits and diseases, with some examples here. Developmentally restricted regulatory elements were especially rich in trait associations.

A neat finding: circulating chromatin also exposed genetic effects on developmental regulatory elements that are reactivated in cancer and hard to sample in adult tissues. cfcQTLs in our cohort were enriched ~16-fold in developmental regulatory elements.

For example, here are chromatin QTLs at risk loci for prostate cancer and kidney cancer. They affect regulatory elements that aren't active in blood cells due to lineage restriction, but are easy to measure in cfChIP data from patients with cancer.

We found thousands of cell-free chromatin QTLs (cfcQTLs): sites where inherited variants are associated with regulatory element activity. Chromatin from cancer provided access to a broad range of regulatory elements not detectable in blood cells.

We analyzed circulating chromatin from >300 patients with cancer. Using cfChIP-seq, we measured histone marks associated with active promoters and enhancers. Germline genotypes imputed from cfChIP-seq reads let us tie genetic variation to differences in histone mark signal.

Blood plasma contains chromatin shed from a wide range of cell types, especially in patients with advanced cancers. We asked if chromatin circulating in blood can report on gene regulation in cell types that are hard to sample.

Many risk variants identified by genome-wide association studies (GWAS) affect regulatory DNA. Understanding how these variants work requires measuring gene regulation in the relevant cell types - not easy in vivo.

Excited to share this paper from @WinstonCheung5 (Ziwei Zhang) and Surya Chhetri in our lab: nature.com/articles/s41467-0…. It shows a cool way that epigenomic liquid biopsy can help us understand human genetics. 🧵

Inspiring to watch cancer centers + industry come together to enable large-scale federated machine learning in oncology. We're working with @CAIAorg to predict lineage plasticity in prostate cancer - cross-institutional validation and scale make all the difference here!

Great collaborating with Ning Shen, @zezhangzzz, and @keegankorthauer on this new paper in @CommsBio! It provides a robust new framework for deconvolving cell type-associated DNA methylation signatures from (cell-free)MeDIP-seq data: nature.com/articles/s42003-0…

Hard to believe that @RazaneHChehade is moving on after a productive postdoc fellowship in the lab. Best of luck on your next steps - @PittPediatrics is very fortunate to have you, and I can't wait to see what you accomplish next!

Proud to see one of my first mentors, Dr. Mary-Ellen Taplin, expanding options for patients with high-risk localized prostate cancer. Congrats to the PROTEUS team on this practice-changing trial! @ASCO @DanaFarber @DanaFarber_GU

A pleasure working with David Lee and @KimmieNgMD on this perspective: nature.com/articles/s41591-0…. Neat approach in the corresponding paper: Using DNA methylation signatures of environmental exposures to investigate what's driving the alarming rise in early-onset colorectal cancer.

Congratulations @zezhangzzz on your scholar-in-training award at @AACR! I'm thrilled to watch you and the team take cancer diagnostics in new directions and improve patient care.